Lupin launches generic hypertension drug in US market
New Delhi: Drug maker Lupin on Monday announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market.
The company has launched the tablets in strengths of 5 mg, 20 mg, and 40 mg after having received an approval from the United States Food and Drug Administration earlier, Lupin Ltd said in a statement.
The Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment of hypertension.
As per IMS MAT data for July 2017, Benicar tablets had US sales of USD 681 million.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd